🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our amazing ⁦UCSD Gastroenterology⁩ fellowship team - so proud of our program directors and fellows ⁦UC San Diego Health⁩

Our new paper evaluating the link between PNPLA3 and CVD risk- PNPLA3 Inhibition and Cardiometabolic Risk: Reassessing Dyslipidemia and ASCVD Concerns pubmed.ncbi.nlm.nih.gov/40286941/ Federica Tavaglione Raj VuppaLanchi Quentin M. Anstee Naga Chalasani Liz Cheney MASLD Research Center Luca Valenti

Thomas Cech ⁦The Nobel Prize⁩ winner giving a keynote ⁦UC San Diego Health⁩ medicine research day - talking about his work on RNA and its impact on health and evolution ⁦MASLD Research Center⁩ ⁦UCSD Gastroenterology⁩ ⁦AASLD⁩ ⁦AASLD President⁩ ⁦Satya Nadella⁩

Excited to kickstart 16th Annual Research Symposium ⁦UCSD Gastroenterology⁩ on IBD and Immunology! Great to have outstanding speakers from across the nation ! Thanks ⁦Miguel Regueiro⁩ Scott snapper and Bill Sandborn for joining us ⁦UC San Diego Health⁩ ⁦American Gastroenterological Association (AGA)⁩

Delighted to co-chair the ⁦roypounder.apt⁩ editorial board meeting with Colin and colleagues from around the 🌎 - full house & great excitement- still remains the fastest decision GI journal no fees #ddw ⁦American Gastroenterological Association (AGA)⁩ ⁦ACG⁩ ⁦AASLD⁩

Great body of collaborative work from our international team that we organized MASLD Research Center Expert Consensus Delphi Panel in MetALD: Opportunities and Challenges in Clinical Practice pubmed.ncbi.nlm.nih.gov/40315973/ AASLD EASLnews Luis Antonio Díaz, MD Juan Pablo (JP) Arab, MD 

At week 24, Efimosfermin 300mg once monthly vs placebo resulted in: ⬇️ 44.6% Pro-C3 ⬇️ 0.7 ELF score ⬇️ 10.1% Pro-C6 ⬇️ 9.2% CTX-3

Nice work led by Luis Antonio Díaz, MD and Veeral Ajmera MASLD Research Center UCSD Gastroenterology inherited risk predicts age-associated increases in fibrosis in patients with MASLD pubmed.ncbi.nlm.nih.gov/40334848/

Prescribing therapies for MASH but unsure of treatment response? The MASH Resolution Index, or FAST score may be helpful 🔥off the press HEPATOLOGY Journal Rohit Loomba AASLD journals.lww.com/hep/abstract/9…

Can FIB-4 then VCTE detect sig. fibrosis in MetALD? = Yes read Luis Antonio Díaz, MD paper MASLD Research Center Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver diseas… pubmed.ncbi.nlm.nih.gov/40377491/ AASLD Elliot Tapper

At #EASL2025, AASLD President Dr. Grace Su chaired 2 sessions, EASL/AASLD Endpoints Conference on #MetALD & ALD, and General Session I, underscoring our commitment to #liverdisease. Thanks to all who grabbed the #TLM25 Preliminary Guide at the Hub—see you in D.C. in November!

#LeadershipYou conference listening to amazing leaders. ACG Dr John Carethers, MD, FACG highlighting honesty and relationships as the 🔑 to incredible leadership careers! Grateful to Andrew Moon Joshua M. Steinberg, MD & many others for their work & generosity!

Our new paper on Efimosfermin alfa (BOS-580), a long-acting FGF21 analogue, in participants with MASH: a randomised, phase 2a trial - The Lancet Gastroenterology & Hepatology thelancet.com/journals/langa… Manuel Romero-Gómez Daniel Huang Naim Alkhouri Mazen Noureddin, MD, MHSc Quentin M. Anstee Christopher A. Longhurst, MD

Great meeting GUILD Conference - highly recommended GI and liver CME Uma Mahadevan Norah Terrault !

Thanks Michael V. Drake for recognizing our UCSD Gastroenterology team UC San Diego Health — gratitude 🙏 ucnet.universityofcalifornia.edu/employee-news/… Patty Maysent Christopher A. Longhurst, MD Saul Karpen American Gastroenterological Association (AGA) ACG AASLD

Excellent data on Mazdutide on weight loss - look forward to data on changes in Liver fat by MRI-PDFF in future!

Keep it up Federica Tavaglione ! Way to go! Thanks Journal of Hepatology !

New data Luis Antonio Díaz, MD MASLD Research Center on use of once monthly injectable naltrexone in patients with advanced ALD -Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of AUD in Adv… pubmed.ncbi.nlm.nih.gov/40515940/ AASLD

Keep it up Luis Antonio Díaz, MD ! This is a key piece that other liver centers can use to change their protocol to give injectable once a month naltrexone to their advanced ALD patients before discharge from the hospital.

Great line up of speakers!!!